This article was originally published in Pharmaceutical Approvals Monthly
Executive SummaryBarr launches generic fluoxetine 20 mg on Aug. 2 at $2.67 average wholesale price per capsule, a 10% discount to Lilly's Prozac. Following a July 27 decision in Indianapolis district court, Barr, Par and Geneva have 180 days of exclusivity on their different fluoxetine formulations. Geneva's 10 mg capsule is $2.60 AWP. Par's formulations will be $2.60 AWP for a 10 mg tablet, $2.67 for a 20 mg tablet and $5.34 for a 40 mg capsule. A June Decision Resources survey of 72 primary care physicians who are high-volume prescribers of antidepressants indicated that 20-25% of physicians will maintain Prozac loyalty for newly diagnosed patients. "Preference for the branded product drops dramatically for existing patients, for whom weekly Prozac is another option," DR said
You may also be interested in...
Abbott is encouraged by results from two studies of its Proclaim XR neurostimulation system for chronic pain, presented at the annual North American Neuromodulation Society (NANS) meeting in Las Vegas. See what Steven Falowski of Neurosurgical Associates of Lancester in Pennsylvania said about it here.
While disappointing result will probably put an end to single-drug plans in ovarian cancer, the blockbuster anti-PD-1 immunotherapy remains in combination development for the indication.
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.